109 related articles for article (PubMed ID: 8398327)
1. Steroid receptor enhancement by natural interferon-beta in advanced breast cancer.
Sica G; Iacopino F; Lama G; Amadori D; Baroni M; Lo Sardo F; Malacarne P; Marchetti P; Pellegrini A; Zaniboni A
Eur J Cancer; 1993; 29A(3):329-33. PubMed ID: 8398327
[TBL] [Abstract][Full Text] [Related]
2. Effect of interferon alpha-2a on hormone receptor status in patients with advanced breast cancer.
Kornek G; Reiner A; Sagaster P; Stierer M; Mayer A; Ludwig H
Cancer Invest; 1999; 17(3):189-94. PubMed ID: 10099657
[TBL] [Abstract][Full Text] [Related]
3. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.
Namer M; Lalanne C; Baulieu EE
Cancer Res; 1980 May; 40(5):1750-2. PubMed ID: 7371003
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells.
Angioli R; Untch M; Sevin BU; Steren A; Hightower RD; Perras JP; Nguyen HN; Koechli OR; Averette HE
Cancer; 1993 May; 71(9):2776-81. PubMed ID: 8467457
[TBL] [Abstract][Full Text] [Related]
5. Variation of estrogen and progesterone receptor status in breast cancer after tamoxifen therapy.
Melchor JC; Rodríguez-Escudero FJ; Luján S; Corcóstegui B
Oncology; 1990; 47(6):467-70. PubMed ID: 2123023
[TBL] [Abstract][Full Text] [Related]
6. Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancer.
De Cicco Nardone F; Rossiello F; Iacopino F; Benedetto MT; Cinque B; Dell'Acqua S; Sica G
Anticancer Res; 1996; 16(1):161-9. PubMed ID: 8615603
[TBL] [Abstract][Full Text] [Related]
7. [Steroid hormone receptors and cellular proliferative activity following the short-term use of tamoxifen and chlorotrianisene in breast cancer].
Vyshinskaia GV; Murav'eva NI; Shelsputina ZF; Kuz'mina ZV; Nikolaeva TG
Eksp Onkol; 1985; 7(5):66-8. PubMed ID: 4065023
[TBL] [Abstract][Full Text] [Related]
8. Natural interferon-beta treatment and steroid hormone receptors in primary endometrial cancer.
Sica G; Iacopino F; Lama G; Marchetti P; Carenza L; Dell'Acqua S; De Cicco Nardone F; Lombardi A; Mariani L; Villani C
Gynecol Oncol; 1993 Aug; 50(2):185-90. PubMed ID: 8375733
[TBL] [Abstract][Full Text] [Related]
9. Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?
Karck U; Kommoss F
Eur J Cancer; 2000 Sep; 36 Suppl 4():S45-6. PubMed ID: 11056315
[TBL] [Abstract][Full Text] [Related]
10. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
11. [Tamoxifen-induced progesterone receptors in breast tumors].
Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and beta-interferon: effect of simultaneous or sequential treatment on breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(2):315-9. PubMed ID: 7763000
[TBL] [Abstract][Full Text] [Related]
13. The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.
Rutqvist LE; Cedermark B; Fornander T; Glas U; Johansson H; Nordenskjöld B; Rotstein S; Skoog L; Somell A; Theve T
J Clin Oncol; 1989 Oct; 7(10):1474-84. PubMed ID: 2674335
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
[TBL] [Abstract][Full Text] [Related]
15. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
16. Recombinant interferon-alpha 2b affects proliferation, steroid receptors and sensitivity to tamoxifen of cultured breast cancer cells (CG-5).
Sica G; Iacopino F; Della Cuna GR; Marchetti P
Anticancer Drugs; 1992 Apr; 3(2):147-53. PubMed ID: 1525393
[TBL] [Abstract][Full Text] [Related]
17. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
[TBL] [Abstract][Full Text] [Related]
18. Modulation of receptor levels in canine breast tumors by administration of tamoxifen and etretinate either alone or in combination.
Cappelletti V; Granata G; Miodini P; Coradini D; Di Fronzo G; Cairoli F; Colombo G; Nava A; Scanziani E
Anticancer Res; 1988; 8(6):1297-301. PubMed ID: 3218961
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor status of breast cancer metastases.
Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone receptor-positive advanced breast cancer.
Connolly RM; Stearns V
Oncology (Williston Park); 2013 Jun; 27(6):571-2, 574, 576 passim. PubMed ID: 23909072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
